Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.ncbi.nlm.nih.gov › pmc › articlesBotulinum toxin use in patients with post-stroke spasticity: a...

   www.ncbi.nlm.nih.gov › pmc › articles

   23 sie 2023 · BoNT-A, administered as a local intramuscular injection, is considered as a first-line pharmacological treatment of spasticity, with a strong body of evidence for its efficacy and safety in the management of both upper and lower limb spasticity (4, 8, 9, 12, 14–17).

2. www.ahajournals.org › doi › 10Poststroke Spasticity Management | Stroke - AHA/ASA Journals

   www.ahajournals.org › doi › 10

   13 wrz 2012 · Lower extremity spasticity can limit ambulation, such as when an equinovarus foot prevents the foot flat position during the stance phase of gait, resulting in instability, and resulting in knee pain attributable to excessive recurvatum when ankle plantar flexor spasticity overwhelms.

3. link.springer.com › article › 10Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity...

   link.springer.com › article › 10

   • Zapisane w pamięci cache

   8 sty 2019 · Several studies have shown that appropriate treatments for lower limb spasticity after stroke include injections of botulinum toxin type A (BoNT-A), phenol or alcohol, surgical correction and a rehabilitation program.

4. www.mdpi.com › 2072/6651/16-2 › 98Best Practice Guidelines for the Management of Patients with Post...

   www.mdpi.com › 2072/6651/16-2 › 98

   • Zapisane w pamięci cache

   10 lut 2024 · Summary: DN can be useful as an adjuvant therapy and should be combined with rehabilitation therapy to reduce post-stroke spasticity only in the lower extremities at short-term follow-up (1 week), but is not effective when evaluated at 4 weeks .

5. www.medicaljournals.se › jrm › contentA practical guide to optimizing the benefits of post-stroke...

   www.medicaljournals.se › jrm › content

   • Zapisane w pamięci cache

   A dose of 800 U of incobotulinumtoxinA enabled more than 97% of patients with cerebral-origin spasticity to receive simultaneous treatment of the upper and lower limb, and more patients achieved 3 or 4 goals (87%) with 800 U than with the lower dose (25% in the 400 U group).

6. pmc.ncbi.nlm.nih.gov › articles › PMC8772370A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE...

   pmc.ncbi.nlm.nih.gov › articles › PMC8772370

   20 paź 2024 · A group of doctors from around the world, who are experts in treating muscle stiffness and spasm (also called spasticity), reviewed the current scientific evidence supporting the effectiveness of using botulinum toxin injections in treatment of spasticity that results from a stroke.

7. pmc.ncbi.nlm.nih.gov › articles › PMC6950173Botulinum Toxin Therapy Combined with Rehabilitation for Stroke:...

   pmc.ncbi.nlm.nih.gov › articles › PMC6950173

   PMCID: PMC6950173 PMID: 31817426. Abstract. Aim: The purpose of this study was to examine the effectiveness of botulinum toxin A (BoNT-A) therapy combined with rehabilitation on motor function in post-stroke patients.